financetom
Business
financetom
/
Business
/
Compounded semaglutide poses serious U.S. health issue, Novo Nordisk CEO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Compounded semaglutide poses serious U.S. health issue, Novo Nordisk CEO says
Mar 8, 2024 2:43 AM

COPENHAGEN, March 8 (Reuters) - Novo Nordisk's

CEO on Friday said compounded semaglutide in the

United States is a serious health issue.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved